Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-09-29 Purchase | 2020-10-01 4:13 pm | Cue Biopharma Inc. | CUE | Gray Cameron Director | 10,000 | $15.15 | $151,500 | 677,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-06-14 Tax Withholding | 2022-06-16 4:01 pm | N/A N/A | Cue Biopharma Inc. | CUE | Gray Cameron Director | 51,562 | $3.2 | 687,049 (Direct) | View |
2022-06-14 Exercise | 2022-06-16 4:01 pm | N/A N/A | Cue Biopharma Inc. | CUE | Gray Cameron Director | 61,111 | $2.7 | 687,049 (Direct) | View |
2022-06-14 Exercise | 2022-06-16 4:01 pm | 2015-06-15 2022-06-15 | Cue Biopharma Inc. | CUE | Gray Cameron Director | 61,111 | $0 | 687,049 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 8:21 pm | N/A 2032-01-02 | Cue Biopharma Inc. | CUE | Gray Cameron Director | 10,000 | $0 | 10,000 (Direct) | View |
2020-12-02 Ownership | 2021-02-01 5:41 pm | N/A N/A | Cue Biopharma Inc. | CUE | Gray Cameron Director | 1,029,800 | $0 | 352,300 (Direct) | View |
2021-01-04 Option Award | 2021-01-06 4:39 pm | N/A 2031-01-03 | Cue Biopharma Inc. | CUE | Gray Cameron Director | 10,000 | $0 | 10,000 (Direct) | View |
2020-01-02 Option Award | 2020-01-06 5:54 pm | 2021-01-02 2030-01-02 | Cue Biopharma Inc. | CUE | Gray Cameron Director | 8,000 | $0 | 8,000 (Direct) | View |